Parameter | Value |
---|---|
Demographics: | Â |
   Age (years) | 64.0 (10.9) |
   Females, n (%) | 92 (66.7) |
   Duration of RA (years) | 17.6 (13.6) |
   RF positive, n (%) | 83 (61.0) |
CV disease: | Â |
   History of MI, n (%) | 14 (10.1) |
   History of angina, n (%) | 11 (8.0) |
   History of stroke/TIA, n (%) | 9 (6.5) |
   History of PVD, n (%) | 6 (4.4) |
   Any vascular event, n (%) | 26 (18.8) |
Risk factors for CV diseases: | Â |
   Smoking pack-year history | 18 (24) |
   Current smoker, n (%) | 25 (18.1) |
   History of hypertension, n (%) | 47 (34.1) |
   History of hyperlipidemia, n (%) | 33 (23.9) |
   History of diabetes, n (%) | 19 (13.8) |
   Family history CV disease, n (%) | 38 (27.5) |
Clinical findings: | Â |
   BMI (kg/m2) | 27.5 (6.9) |
   Systolic BP (mmHg) | 132 (19) |
   Diastolic BP (mmHg) | 78 (10) |
Laboratory tests: | Â |
   ESR (mm/h) | 25 (18) |
   CRP (mg/l) | 13.6 (18.6) |
   Total cholesterol (mmol/l) | 5.3 (1.0) |
   HDL cholesterol (mmol/l) | 1.5 (0.4) |
   LDL cholesterol (mmol/l) | 3.0 (0.9) |
   TG (mmol/l) | 1.6 (1.0) |
   Homocysteine (μmol/l) | 12 (5) |
   Fasting glucose (mmol/l) | 5.6 (1.6) |
   Serum creatinine (mmol/l) | 0.08 (0.05) |
   CrCl (ml/min) | 79.1 (29.9) |
   Framingham score (%) | 11.1 (9.5) |
   ECG evidence of ischemia, n (%) | 2 (1.5) |
Severity and feature of RA: | Â |
   Radiographic erosion score | 24 (35) |
   Joint space narrowing score | 21 (28) |
   Presence of erosive disease, n (%) | 97 (71.3) |
   History of vasculitis, n (%) | 15 (10.9) |
   Shared epitope, n (%) | 103 (75.2) |
   > 10 mg/day of prednisone, n (%) | 9 (6.5) |
   RAGE polymorphism, n (%) | 29 (21.0) |